Compare BridgeBio Pharma Inc (BBIO) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Wolfspeed Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Wolfspeed Inc trades at $35.12 (market cap $1.75B). The key difference: BridgeBio Pharma Inc is far larger — about 9.3× Wolfspeed Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Wolfspeed Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | WOLF | |
|---|---|---|
Market Cap | $16.27B | $1.75B |
Sector | Health | Technology |
52-Week High | $90.17 | $73.68 |
52-Week Low | $44.81 | $1.19 |
Enterprise Value | $17.82B | $2.41B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
